News

Stealth received the FDA's so-called 'complete response letter' after a 16.5-month review, during which the FDA extended its ...
Spun off from Novartis in 2019, Alcon is betting on new product launches to accelerate sales growth in the second half of ...
The U.S. Food and Drug Administration has asked for a resubmission of Stealth BioTherapeutics' marketing application for its ...
“Reported cases were rare but sometimes serious, with patients experiencing widespread, severe itching that required medical ...
By Lori Solomon HealthDay ReporterTUESDAY, May 27, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...
If coronavirus vaccines are restricted to seniors and those at high risk, parents of young children and relatives of ...
The U.S. Food and Drug Administration is warning that certain half-shell oysters that are frozen and raw harvested in South ...
Daiichi Sankyo, along with partner Merck & Co., has pulled an FDA approval filing for an antibody-drug conjugate (ADC) cancer ...
Instead, Stealth submitted a new drug application (NDA) seeking approval of elamipretide and the FDA issued its ...
Instead of approving Stealth BioTherapeutics' drug for Barth syndrome, the FDA withheld its endorsement, but decided it may ...
The U.S. Food and Drug Administration cleared the first in vitro diagnostic device that tests blood to aid in diagnosing ...
The FDA approved Tryptyr to treat the signs and symptoms of dry eye disease, according to a press release from Alcon. Tryptyr ...